BCM
Bayesian Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $572K | Sell |
10,400
-23,700
| -70% | -$1.3M | 0.09% | 257 |
|
|
2025
Q1 | $2.41M | Buy |
34,100
+23,000
| +207% | +$1.63M | 0.4% | 66 |
|
|
2024
Q4 | $730K | Sell |
11,100
-9,722
| -47% | -$639K | 0.09% | 298 |
|
|
2024
Q3 | $1.46M | Buy |
+20,822
| New | +$1.46M | 0.17% | 178 |
|
|
2023
Q1 | – | Sell |
-20,304
| Closed | -$2.1M | – | 794 |
|
|
2022
Q4 | $2.1M | Buy |
+20,304
| New | +$2.1M | 0.31% | 59 |
|
|
2021
Q1 | – | Sell |
-2,419
| Closed | -$212K | – | 540 |
|
|
2020
Q4 | $212K | Sell |
2,419
-401
| -14% | -$35.1K | 0.06% | 371 |
|
|
2020
Q3 | $215K | Buy |
+2,820
| New | +$215K | 0.05% | 428 |
|
|
2017
Q3 | – | Sell |
-5,200
| Closed | -$472K | – | 482 |
|
|
2017
Q2 | $472K | Buy |
+5,200
| New | +$472K | 0.17% | 196 |
|